22 May 2013
Keywords: positive, ph, ii, data, novartis, indacaterol, switzerland
Article | 30 May 2005
Switzerland's number one drugmaker Novartis says that its indacaterol may provide a new standard for beta 2 agonist therapy in patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 May 2005
21 May 2013
© 2013 thepharmaletter.com